# TEGSEDI
> **NDA211172** · New Drug Application · Sponsor: AKCEA THERAPS · Approved 2018-10-05
## Drug
- **FDA Application Number:** NDA211172
- **Application type:** New Drug Application
- **Brand name:** TEGSEDI
- **Generic name:** Inotersen Sodium
- **Active ingredients:** INOTERSEN SODIUM
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** AKCEA THERAPS
- **First approval:** 2018-10-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211172)
---
*MORVS · CC0 1.0*